INTEGRA LIFESCIENCES HOLDINGS CORP (IART) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4579852082
INTEGRA LIFESCIENCES HOLDINGS CORP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.64 bn USD |
| Gross profit | 831.62 m USD |
| Operating income | -493.37 m USD |
| EBIT | -495.72 m USD |
| Net income | -516.47 m USD |
| Diluted EPS – continuing operations | -6.74 USD |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About INTEGRA LIFESCIENCES HOLDINGS CORP
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
More stocks
- Huadian Heavy Industries Co (601226.SS)
- Retail Estates NV (RET.BR)
- STORAGE KING GROUP UNITS (SKG.AX)
- Ambiq Micro, Inc. (AMBQ)
- DELUXE CORP (DLX)
- Starlake Bioscience Co Inc Zhaoqing Guangdong (600866.SS)
- Flaircomm Microelectronics Inc Ordinary Shares - Class A (301600.SZ)
- Guangzhou KDT Machinery Co Ltd (002833.SZ)
- Alliance Material Co., Ltd. (3595.TWO)
- Corticeira Amorim SGPS SA (COR.LS)
- Cibus Nordic Real Estate AB (publ) (CIBUS.ST)
- Ningbo Changhong Polymer Scientific & Technical Inc (605008.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.